ASN95 -- Selected abstracts: Membranous Nephropathy

Sun. Nov. 5 1995

4:00 P.M. ---Free communications--- San Diego Conv Ctr Rm 2
therapy of glomerular disease

Program number 726 at 4:00
* Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 years follow-up of a prospective, randomized multi-center study. N. Braun, C. M. Erley, N. Benda, I. Zauner, R. Kanis, C. Grupp, M. Ackermann, P. Heering, R. Funfstuck and T. Risler. - Tubingen, Germany.

Program number 727 at 4:15
* Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. S. Ambalavanan, J. P. Fauvel and B. D. Myers. - Stanford, CA.

Program number at 5:15
* Invited lecture: Efficient anti-proteinuric effect of lipid peroxidation inhibitors in membranous nephropathy. - Dontscho Kerjaschki. - Vienna, Austria.

Mon. Nov. 6 1995

4:00 P.M. ---Free communications--- San Diego Conv Ctr Rm 3
glomerular syndromes

Program number 1381 at 4:30
* Urinary c5b-9 excretion and clinical course in idiopathic human membranous nephropathy. S. P. Kon, B. Coupes, C. D. Short, L. R. Solomon, M. J. Raftery, N. P. Mallick and P. E. C. Brenchley. - London, United Kingdom.

Program number 1385 at 5:30
* Characterization of glomerular antigen of membranous nephropathy (MN) in the syndrome of MN, tubulointerstitial nephritis and Fanconi syndrome. S. P. Makker, R. Widstrom and J. Huang. - Davis, CA.

Tue. Nov. 7 1995

9:00 A.M. ---Poster highlights--- San Diego Conv Ctr Halls A and B
glomerular diseases

Program number 1549 at na
* Protein A immunoadsorption reduces proteinuria in patients with membranous nephropathy. D. P. Besnier, S. Martin, D. Chabannes, A. Testa, P. Simon and V.L.M. Esnault. - Nantes, France.

Program number 1550 at na
* Novel association between HLA DQ A1*05 and membranous glomerulonephritis. R. Perrichot, B. Mercier, B. Wehbe, J. P. Lenormand, O. Raguenes, C. Ferec and J. Cledes. - Brest, France.

Program number 1551 at na
* Strong association of HLA-DQB2 in Sardinian patients with idiopathic membranous nephropathy. A. Pani, P. Altieri, S. Devirgiliis, A. Cao, R. Lampis, F. Frau, P. Melis, M. Arnone, P. Piras, A. Fresu, F. Cucca and M. Congia. - Cagliari, Italy.

Program number 1552 at na
* Urinary c5b-9 in early and advanced renal insufficiency in membranous nephropathy. M. Schulze, R. Brunkhorst, J. Floege, C. Kurts and K-M. Koch. - Hanover, Germany.

Program number 1553 at na
* Participation of antibodies to RO/SS-A in the pathogenesis of membranous nephropathy. M. Okamura, M. Nishimura, Y. Konishi, K. Inoue, C. K. Young, T. Yoshioka, N. Negoro, T. Inoue and Y. Kanayama. - Osaka, Japan.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
mechanisms of glomerulonephritis

Program number 1579 board# t129 at 10:00 A.M.
* Immunohistochemical detection of a glomerular antigen in human membranous nephropathy. I.S.D. Roberts, J. Mcguire, C.D. Short and P.E.C. Brenchley. - Manchester, United Kingdom.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
clinical transplantation i

Program number 1806 board# t356 at 10:00 A.M.
* Clinical picture and outcome of allograft membranous glomerulonephritis in renal transplant patients with hepatitis C virus infection. J.M. Morales, G. Fernandez-Zatarain, M.A. Munoz, G. Usera, M.A. Martinez, A. Fuertes, A. Andres and J.L. Rodicio. - Madrid, Spain.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.